1 study found for:    20113890 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim
Condition: Severe Combined Immunodeficiency
Interventions: Drug: Transplant Conditioning with Mobilization Only;   Drug: Transplant Conditioning with Mobilization and Alemtuzumab

Indicates status has not been verified in more than two years